Hematopoietic stem cells (HSCs) are characterized by the capacity for self-renewal and the ability to reconstitute the entire hematopoietic compartment. Thrombopoietin maintains adult HSCs in a quiescent state through the induction of cell cycle inhibitors p57 growth factor b1 secretion. This leads to fibrosis in the bone marrow and spleen, followed by loss of HSCs during aging.
INTRODUCTION
Hematopoietic stem cells (HSCs) possess the capacity for self-renewal and multilineage differentiation that underlies the maintenance and reconstitution of the entire hematopoietic compartment. In the bone marrow (BM), the majority of HSCs remain quiescent in the G0 phase of the cell cycle. Upon exposure to stress, the number of mature cells in the blood circulation is reduced, causing quiescent HSCs to enter the cell cycle and replenish the hematopoietic system.
Accumulating evidence has demonstrated that quiescence is an active process regulated by intrinsic factors, including numerous transcription factors, as well as environmental cues, including the Notch, Wnt, and Sonic hedgehog signaling pathways. Cytokines also play a major role in regulating the HSC cell cycle. For example, thrombopoietin (TPO), the primary regulator of megakaryocyte (MK) differentiation, is required for the maintenance of adult HSC quiescence, via induction of the cell cycle inhibitors, p57
Kip2 and p19 INK4d (Qian et al., 2007; Yoshihara et al., 2007) . TGF-b1 can also enforce HSC quiescence by inducing p57 Kip2 expression (Scandura et al., 2004; Yamazaki and Nakauchi, 2009 ). Cyclin-dependent kinase inhibitors (CDKIs) directly control the cell cycle by inhibiting cell cycle entry. They are divided into two groups: the INK4 family and the Cip/Kip family.
Cip/Kip proteins are expressed at higher levels in HSCs than in progenitor cells (Passegué et al., 2005) . The role of p21
Cip1 in HSCs is restricted to cell cycle regulation under stress conditions (van Os et al., 2007) . p27 Kip1 deficiency does not affect HSC numbers or HSC self-renewal, but alters the proliferation of progenitor cells (Cheng et al., 2000a) . p57 Kip2 is an important regulator of hematopoiesis in the aorta gonads mesonephros region, where HSCs emerge (Mascarenhas et al., 2009) . Inducible loss of p57 Kip2 in hematopoietic cells has demonstrated the critical role of this CDKI in the maintenance of HSC quiescence (Matsumoto et al., 2011) . More recent studies have implicated INK4 members in the control of HSC functions. p16
INK4a expression is repressed by EZH1 in young animals (Hidalgo et al., 2012) . Its expression increases with age, contributing to the decreased self-renewal, homing, and repopulating activities of HSCs in response to stress (Janzen et al., 2006) . However, the role of p16 INK4a in regulating steady-state HSC aging in vivo appears to be less important (Attema et al., 2009 ). p18 INK4c is also involved in the senescence of HSCs. In its absence, the number of cycling HSCs increases, although the overall self-renewal capacity of the HSC compartment INK4d in different populations of C57BL/6 and C57BL/6-Sv129j mice: SLAM (Lin
, and MEP (Lin
. Each population represents a pool derived from 10 mice. Data are normalized to HPRT transcript levels and represent the mean ± SEM of triplicates. (B) BM cellularity (n = 10). (C-E) Immunophenotype (C) and number of LSK (D) and SLAM (E) cells (n = 8).
(F-I) Immunophenotype (F) and number of total SP (G), lymphoid SP (H), and myeloid SP (I) populations (n = 4). Mice that were 8 to 10 weeks old were used. KO, p19 INK4dÀ/À . Data represent mean ± SEM. *p < 0.05, **p < 0.01, unpaired t test. See also Figure S1 .
Stem Cell Reports j Vol. 3 j 1085-1102 j December 9, 2014 j ª2014 The Authors 1087 Stem Cell Reports LSK (2.6-fold) and SLAM (11.6-fold) cell numbers, with a concomitant increase in G1 phase cells, whereas no differences in the number of cells in S/G2-M phases were observed ( Figures 3C and 3D) .
To Figure 3L ).
To differentiate the cell-autonomous and environmental effects of p19
INK4d on the cell cycle ( Figures 3M and 3N) and apoptosis (Figures 3O and 3P) following induction of stress, a lower dose of 5-FU (50 mg/kg) was injected into the chimeric mice 2 months after reconstitution. Within 48 hr, a more rapid exhaustion of quiescent p19
INK4dÀ/À LSK ( Figure 3M ) and SLAM ( Figure 3N ) cells was observed compared with WT cells, regardless of the genetic background of the recipient mice. This cell cycle re-entry was accompanied by an increased percentage of p19
INK4dÀ/À cells in G1 and S/G2-M phases ( Figures 3M, 3N , S2E, and S2F). Increased apoptosis was also detected in both LSK ( Figure 3O ) and SLAM ( Figure 3P ) p19 Mice that were 8 to 10 weeks old were used. KO, p19 INK4dÀ/À . Data represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, unpaired t test. and 5B). In contrast, no differences were observed for all other BM myeloid progenitors during aging ( Figures S3A  and S3B ). In peripheral blood, a significant increase in red blood cells and lymphocytes detected in WT mice was not observed in p19 INK4dÀ/À mice ( Figures S3C-S3F ). In contrast, the slight increase in platelet counts observed in young p19 INK4dÀ/À animals was more pronounced (1.35-fold) in p19 INK4dÀ/À mice that were older than 91 weeks ( Figure S3F ). To determine whether the increased MK-P number has consequences on the total MK cell population, we performed a histological examination of BM and spleen from mice of different ages. Accumulation of clustered, polylobulated MKs ( Figure S3G ) in the BM and spreading of the red pulp ( Figure S3H ) in the spleen of p19 (Figures 5D and 5F) revealed that the total MK number increased progressively with age in BM of WT mice. However, this increase occurred more rapidly in the BM of p19
INK4dÀ/À mice, reaching a plateau at 20-25 weeks (3.4-fold increase) ( Figure 5C ). A 6.2-fold increase in the number of MKs was observed in the spleen of aged 19 INK4dÀ/À mice, whereas MK numbers remained constant in the spleen of aged WT mice ( Figure 5D ). Since p19 INK4d regulates MK ploidization arrest (Gilles et al., 2008) , we next investigated MK ploidy ( Figure 5G ). Regardless of age, the modal ploidy level remained 64N in p19 INK4dÀ/À mice compared with 16N for WT MKs ( Figure 5H ). However, a progressive increase in the proliferative 2N/4N MK population was noted in BM during aging ( Figure 5I Figure 5M ). These results indicate that MK amplification is due to an intrinsic role of p19
INK4d
.
The loss of p19
INK4d therefore mimics hematopoietic stress, which is normally associated with hematopoietic development in the spleen and induction of splenomegaly. Accordingly, the spleen size did not change for WT mice during aging, whereas a 1.4-fold increase in spleen size for p19 INK4dÀ/À mice was already observed at 8-10 weeks of age. This effect became more pronounced as a function of age ( Figure 6A ) and was associated with a parallel increase in spleen cellularity ( Figure 6B ). To determine the role of the microenvironment in the splenomegaly, spleen weights were determined for 8-month-old chimeric mice. A significant increase in spleen weight was detected when WT and p19 INK4dÀ/À recipient mice were reconstituted with p19 INK4dÀ/À cells ( Figure 6C ), suggesting an intrinsic role of p19 INK4d in extramedullary hematopoiesis.
An enhanced MK mass is typically associated with increased TGF-b1 secretion. The levels of active and latent TGF-b1 in the extracellular fluids from BM and spleen directly paralleled MK numbers in BM and spleen during aging (Figures 6D-6G) . Nonetheless, the level of active TGFb1 increased in the BM of p19
INK4dÀ/À mice until 20-25 weeks of age, after which it decreased again ( Figure 6D ). In the spleen, a strong increase was also already observed at 20-25 weeks ( Figure 6F ). The presence of active TGF-b1 in tissues is usually associated with fibrosis. Increased reticulin fiber deposition was observed during aging in p19 INK4dÀ/À mice. In mice older than 91 weeks, fibrosis was detected in the spleens of all p19 INK4dÀ/À mice (Figure 6H ) and in the BM of 20% of mice ( Figure S4A ). Osteosclerosis could also be observed in these mice ( Figure S4B , upper panels). Consistent with the changes observed in myelofibrosis, we also detected an increase in circulating myeloid (Lin À Sca1 À Kit + ) progenitors ( Figure 6I ) and LSK cells ( Figure 6J ) in older mice. To investigate whether fibrosis was a consequence of abnormal hematopoiesis, we transplanted a pool of total BM and spleen cells from p19
INK4dÀ/À mice with myelofibrosis and a spleen weight of 4 g into lethally irradiated WT recipients. At 6 weeks posttransplantation, splenomegaly was detected in primary recipients and in a less pronounced manner also in secondary recipients ( Figure S4C) . No osteosclerosis or fibrosis of the BM was observed (Figure S4B ). However, fibrosis was detected in the spleen of both primary and secondary recipients, and this correlated with the increased MK numbers ( Figure S4D ). These results indicate that the disease is transplantable and that it originates in the hematopoietic system. HSC pool (Scandura et al., 2004; Yamazaki and Nakauchi, 2009) , while DNA damage accumulates in HSCs during aging (Rossi et al., 2007) . As we demonstrated above, p19
INK4d
protects HSCs from apoptosis during genotoxic stress. Loss of p19
INK4d could then alter the HSC pool during aging in both an intrinsic and extrinsic manner. Therefore, the number of LSK and SLAM cells was studied in aged animals ( Figure 7A) . No difference was observed in LSK cells during aging ( Figure 7B ). In agreement with previously published work (Beerman et al., 2010) , we observed a 3-fold increase in SLAM cell numbers in WT mice more than 48 weeks old compared with 8-to 10-week-old mice, while only a slight increase was observed in the SLAM population of p19 INK4dÀ/À mice ( Figure 7C) . No difference in the total clonogenic potential between WT and p19 INK4dÀ/À SLAM cells from mice that were more than 48 weeks old was detected by in vitro assay on OP9/OP9D1 cell lines ( Figure 7D ). The proportion of HSCs with myeloid potential increases with age, and this occurs at the expense of lymphoid potential (Beerman et al., 2010) . Investigation of the myeloid versus lymphoid potential during aging ( Figure 7E ) confirmed an increase in HSC number in WT mice (2.2-fold), but not in p19
INK4dÀ/À mice ( Figure 7F ). In 8-to 10-week-old WT and p19 INK4dÀ/À mice, the lymphoid SP subpopulation was increased compared with its myeloid counterpart ( Figures 7G and 7H) . In WT mice, the proportion of myeloid SP increased 3.6-fold in old mice compared with young mice, and it exceeded the lymphoid SP fraction by 1.15-fold ( Figures 7G and 7H ). Moreover, p19
INK4d expression increased during aging in WT mice ( Figure 7I ). In contrast, the myeloid SP population in p19
INK4dÀ/À mice was only slightly amplified during aging, and no inversion in the ratio of lymphoid and myeloid SP was detected ( Figures 7G and 7H Figure 7K ) and SLAM cell numbers ( Figure 7M) Figure 7N ) that was associated with a slight increase in P-H2AX accumulation in p19 
DISCUSSION
We report here that the p19 INK4d CDKI plays at least two important roles in regulation of the HSC pool. One of these is cell autonomous and manifests itself under conditions of stress. The second role relates to the microenvironment and underscores the role of p19 INK4d in mediating agerelated effects on the HSC pool. Lead to the Development of Fibrosis (A and B) Spleen weight (A) and cellularity (B) of 8-to 10-week-old (n = 5), 20-to 25-week-old (n = 5) and >91-week-old (n = 6 for WT and n = 14 for KO) mice. Each dot represents data from a single mouse. The * shows the differences between WT and KO mice, and the 00 shows differences between 8-to 10-week-old and 20-to 25-week-old mice or between 8-to 10-week-old and >91-week-old KO mice.
(legend continued on next page)
